Absa also reported on the same period last week. Deposits grew by 12% but gross loans and advances only increased by 7%.
The Blue Label share price has had a solid run recently but is down more than 66% over the past five years. There are many other elements to the transaction. In summary, Blue Label is giving Cell C another significant punt and is taking some big risks along the way. The company will hold 49.3% in Cell C once all the steps are completed.
There is some respite for shareholders, as EOH has announced the sale of four subsidiaries for about R420-million. The earnings before interest, tax, depreciation and amortisation multiple for the sale is about 5x, which isn’t exciting.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: